These telomeric replication defects were also observed in human cancer cells subjected to shRNA-mediated Stn1 knockdown, although telomere lengths and cellular proliferation rates did not appear to be affected (Dai et al., 2010; Stewart et al., 2012; Wu et al., 2012). Here, STN1 is linked to cancer.